The incidence and severity of nifedipine-induced gingival overgrowth.
about
The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.A clinical review of drug-induced gingival overgrowths.Dental plaque-induced gingival diseases.Treatment of drug-induced gingival enlargement: aesthetic and functional considerations.Idiopathic gingival enlargement and its management.Clinical assessment of nifedipine-induced gingival overgrowth in a group of brazilian patients.An update on crown lengthening. Part 1: Gingival tissue excess.Connective tissue metabolism and gingival overgrowth.Prevalence of gingival overgrowth induced by antihypertensive drugs: A hospital-based study.Idiopathic gingival hyperplasia: a case report with a 17-year followup.Oral and dental aspects of chronic renal failure.Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review.Oral manifestations in hypertensive patients: A clinical study.Effects of medications on the periodontal tissues in health and disease.Application of evidence-based dentistry: from research to clinical periodontal practice.The possible potential therapeutic targets for drug induced gingival overgrowth.Calcium channel blocker-induced gingival enlargement.Drugs, medications and periodontal disease.Oral health of pediatric liver transplant recipients.NF-κB Enhances Androgen Receptor Expression through 5'-UTR Binding in Gingival Cells.Subgingival microflora associated with nifedipine-induced gingival overgrowth.Prevalence of gingival enlargement secondary to calcium channel blockers in patients with cardiovascular diseases.Periodontal implications: medically compromised patients.Nifedipine-induced gingival enlargement: Correlation with dose and oral hygiene.Is periodontal health a predictor of drug-induced gingival overgrowth? A cross-sectional study.Gingival overgrowth due to amlodipine.Nonsurgical management of nifedipine induced gingival overgrowth.Does nifedipine aggravate cyclosporin--induced gingival overgrowth? An experiment in rats.Amlodipine-induced gingival overgrowth: periodontal responses to stopping and restarting the drug.Tacrolimus is not associated with gingival overgrowth in renal transplant patients.The gingival inflammatory infiltrate in cardiac patients treated with calcium antagonists.Nifedipine induces periostin expression in gingival fibroblasts through TGF-beta.Inhibition of growth of human gingival fibroblasts by chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1.Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth.Reliability of two measurement indices for gingival enlargement.Prevalence of gingival overgrowth among elderly patients under amlodipine therapy at a large Indian teaching hospital.Gingival overgrowth: Part 1: aetiology and clinical diagnosis.Effect of Calcium Channel Blockers on Gingival Tissues in Hypertensive Patients in Lagos, Nigeria: A Pilot Study.Nifedipine-induced histological changes in the parotid glands of hypertensive rats.
P2860
Q33768650-E1641D2C-585A-4C66-BB8B-D8AE868EC967Q33844744-9A1AF11A-A7E9-4F4C-9CB5-A909128F5EBEQ33906599-037AEAC2-C51B-442E-961C-DA27C224F865Q34364977-CE4E82B8-2058-4B81-9830-E20F4A020DE7Q35053853-348B8289-459A-4CCB-B750-DC45AA32BC50Q35269928-8CD31E3C-4A88-4F34-A46A-C47B492DEC38Q35658571-D1BA2CAD-BB0C-4BC8-8DA0-7033F031D8AFQ35798724-AD0C392F-9487-4D1B-B15A-31ABD9C95186Q35902982-328AAACF-3639-46FD-84B6-9A59BE148A62Q35910666-723382BC-3694-41CB-8F74-3B9307052F4EQ36050817-D50246A1-A495-4D9F-971A-D9699EB7F9C1Q36097981-34F79CF1-A712-45DD-9079-050BBD0D38C8Q36181166-F10266C0-268B-4ABA-967A-78B33D0EDFA3Q36362702-2D3D004D-2E60-48E5-8909-6938988C0DAAQ38002939-97F9E438-A17A-4CF7-9F01-21252A42D9C0Q38108291-C53D9634-E728-4890-81BC-444FA5C65927Q38112252-4C8A9449-3C41-43BB-B190-12268D520D26Q38262447-32F26FD4-5C8F-4B9E-A3EC-87782A968971Q40149770-37326F8A-4FA6-4630-83EA-08CB34E7D45FQ40761082-2746FE90-4028-4275-B4B2-D96862CC1AF6Q40851801-B0DFDB74-0F6F-409F-B7A4-7BC2BDDFCDC8Q41138548-DB4E0E4D-3A08-48C2-9411-17804078A47FQ41444849-151CF67F-D2A1-45A3-B34A-010D40162C66Q41832187-FEA7E789-18F1-4CFE-A505-6750D2069215Q41901984-5C5F6FE5-F27E-4F65-8FB2-83A0ED9D2F89Q42676761-B5DEB581-EF68-4FC1-91CE-405478905460Q42809974-175470F3-184B-4FD0-AB25-66F2172F1A29Q43598374-CBA4D903-E599-417C-9794-D25EB6891990Q43694963-A83BBE70-5C4D-4598-AE5B-E78041418F90Q43700096-F3C36FFF-7D26-43BE-B83B-0973D58D6317Q43784900-B822BED0-2305-4B01-9D79-BE22E5D0DA47Q45023090-BB097C5D-08C6-4197-92A1-F07667972C0AQ45885951-6A05987D-C5E7-44C5-B29E-B76157311C43Q46599834-616188F9-902A-442F-BEDB-7941DEBA0A0EQ46760702-AC700B42-0408-4ADD-B499-AB153B26FD8BQ47257695-730E7B48-BD33-4F9F-96BF-9943BA56661EQ47899482-A373EE67-66A7-4BB6-AAD8-8407AEADE17CQ48855755-856FAC6F-4089-4C90-856A-EBEB675DA14BQ49167042-DF25EC27-DECC-4969-81B3-53AB05DE0677Q50469098-D356A47D-8B7B-43E0-B44C-9A30CE52308C
P2860
The incidence and severity of nifedipine-induced gingival overgrowth.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
The incidence and severity of nifedipine-induced gingival overgrowth.
@en
The incidence and severity of nifedipine-induced gingival overgrowth.
@nl
type
label
The incidence and severity of nifedipine-induced gingival overgrowth.
@en
The incidence and severity of nifedipine-induced gingival overgrowth.
@nl
prefLabel
The incidence and severity of nifedipine-induced gingival overgrowth.
@en
The incidence and severity of nifedipine-induced gingival overgrowth.
@nl
P2093
P1476
The incidence and severity of nifedipine-induced gingival overgrowth.
@en
P2093
P304
P356
10.1111/J.1600-051X.1992.TB00650.X
P407
P577
1992-05-01T00:00:00Z